Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.

GSK Investigational Site, Sofia

GSK Investigational Site, Mendoza

GSK Investigational Site, Pleven

GSK Investigational Site, Panama City

GSK Investigational Site, Prague

GSK Investigational Site, New York

GSK Investigational Site, Berlin

GSK Investigational Site, Córdoba

GSK Investigational Site, Ansan

GSK Investigational Site, La Rochelle

GSK Investigational Site, Granada

GSK Investigational Site, Fayetteville

GSK Investigational Site, Chihuahua City

GSK Investigational Site, Pompano Beach

GSK Investigational Site, Durango

GSK Investigational Site, Vigo

GSK Investigational Site, Dublin

GSK Investigational Site, Guadalajara

GSK Investigational Site, Münster

GSK Investigational Site, Santa Monica

GSK Investigational Site, Fountain Valley

GSK Investigational Site, Shanghai

GSK Investigational Site, Hangzhou

GSK Investigational Site, Chongqing

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Ciudad Autonoma de Bueno

GSK Investigational Site, Córdoba

GSK Investigational Site, Rosario

GSK Investigational Site, Barrie

GSK Investigational Site, London

GSK Investigational Site, Markham

GSK Investigational Site, Shanghai

GSK Investigational Site, Prague

GSK Investigational Site, Athens

GSK Investigational Site, Roma

GSK Investigational Site, Chiba

GSK Investigational Site, Fukuoka

GSK Investigational Site, Fukuoka

GSK Investigational Site, Gunma

GSK Investigational Site, Hokkaido

GSK Investigational Site, Hokkaido

GSK Investigational Site, Kanagawa

GSK Investigational Site, Osaka

GSK Investigational Site, Osaka

GSK Investigational Site, Saitama

GSK Investigational Site, Elblag

GSK Investigational Site, Katowice

GSK Investigational Site, Szczecin

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul